Table 2 Patient data for validation

Sex (male/female)

176/132

57.1/42.9

Age (years)

 Mean ± SD

62.7 ± 15.7

 Median (range)

66 (20–90)

Tumor location

 Tongue/gingival/oral floor/buccal area

129/87/33/23

41.9/28.2/10.7/7.5

 Palate/intraosseous^a/maxillary sinus

16/8/5

5.2/2.6/1.6

 Lip/submandibular gland/sublingual gland

3/2/2

1.1/0.6/0.6

Stage^b

 I/II/III/IV

108/86/19/95

35.1/27.9/6.2/30.8

Treatment

 Operation (Ope)

222

72.1

 Chemotherapy (Chemo)

2

0.6

 Radiation therapy (RT)

2

0.6

 Ope + Chemo/RT

68

22.1

 Chemo + RT

14

4.6

CRP (mg/dL)

0.42 ± 0.60

Alb (g/dL)

4.30 ± 0.44

A/G

1.49 ± 0.31

T-cho (mg/dL)

198.55 ± 37.01

BMI (kg/m²)

21.60 ± 3.50

CAR

0.10 ± 0.17

NLR

2.52 ± 1.35

PLR

156.12 ± 69.29

PNI

51.50 ± 5.63

mGPS (0/1/2)

264/38/6

85.7/12.3/2.0

CONUT (0/1/2/3/4/6/7)

101/100/59/33/12/2/1

32.8/32.5/19.2/10.7/3.9/0.6/0.3

MMV (cm³)

 Male

53.44 ± 14.50

 Female

36.21 ± 9.29